Karanikas G - Search Results

1

Radiation exposure from patients treated with 165Dy-ferric hydroxide.

Havlik E, Pirich C, Preitfellner J, Karanikas G, Schaffarich P, Hefner A, Sinzinger H. Havlik E, et al. Among authors: karanikas g. Nucl Med Commun. 2001 Jan;22(1):79-82. doi: 10.1097/00006231-200101000-00011. Nucl Med Commun. 2001. PMID: 11233556

2

[Thrombocyte function of healthy probands taking 50 mg of acetylsalicylic acid per day].

Sinzinger H, Kritz H, Pirich C, Karanikas G, Kurtaran A, Banyai M, Peskar BA, Rehak P. Sinzinger H, et al. Among authors: karanikas g. Wien Klin Wochenschr. 1995;107(15):457-63. Wien Klin Wochenschr. 1995. PMID: 7676685 Clinical Trial. German.

3

Radiation-induced vascular damage.

Kritz H, Ulm MR, Karanikas G, Sinzinger H. Kritz H, et al. Among authors: karanikas g. Vasa. 1995;24(4):392-5. Vasa. 1995. PMID: 8533454

4

Bradykinin formation during processing for cellular labelling may cause side-effects.

Rodrigues M, Karanikas G, Granegger S, Sinzinger H. Rodrigues M, et al. Among authors: karanikas g. Eur J Nucl Med. 1996 Jul;23(7):857-8. doi: 10.1007/BF00843716. Eur J Nucl Med. 1996. PMID: 8698072 No abstract available.

5

Passive smoking and platelet thromboxane.

Schmid P, Karanikas G, Kritz H, Pirich C, Stamatopoulos Y, Peskar BA, Sinzinger H. Schmid P, et al. Among authors: karanikas g. Thromb Res. 1996 Feb 15;81(4):451-60. doi: 10.1016/0049-3848(96)00017-5. Thromb Res. 1996. PMID: 8907294 Clinical Trial.

6

Methodological reappraisal of platelet radiolabelling with 111indium.

Rodrigues M, Karanikas G, Granegger S, Sinzinger H. Rodrigues M, et al. Among authors: karanikas g. Nucl Med Biol. 1996 Nov;23(8):1023-5. doi: 10.1016/s0969-8051(96)90000-1. Nucl Med Biol. 1996. PMID: 9004293 No abstract available.

7

Acetylsalicylic acid is unlikely to beneficially interfere with radiation-induced vasculopathy.

Sinzinger H, Karanikas G, Kritz H. Sinzinger H, et al. Among authors: karanikas g. Acta Oncol. 1997;36(3):341. doi: 10.3109/02841869709001274. Acta Oncol. 1997. PMID: 9208908 No abstract available.

8

Platelet labeling with 67Ga-MPO: a comparison with 111In-MPO.

Karanikas G, Rodrigues M, Granegger S, Havlik E, Sinzinger H. Karanikas G, et al. Nucl Med Biol. 1998 Feb;25(2):165-8. doi: 10.1016/s0969-8051(97)00159-5. Nucl Med Biol. 1998. PMID: 9468032 Clinical Trial. No abstract available.

9

Vascular wall-rather than platelet PGE1-pretreatment in-vivo (but not in-vitro) decreases thrombogenicity.

Karanikas G, Granegger S, Schima H, Sinzinger H. Karanikas G, et al. Adv Exp Med Biol. 1997;433:431-4. doi: 10.1007/978-1-4899-1810-9_95. Adv Exp Med Biol. 1997. PMID: 9561188 No abstract available.

10

Technetium-99m-tetrofosmin: a new agent for melanoma imaging?

Meghdadi S, Karanikas G, Schlagbauer-Wadl H, Jansen B, Chehne F, Rodrigues M, Pehamberger H, Sinzinger H. Meghdadi S, et al. Among authors: karanikas g. Anticancer Res. 1998 Jul-Aug;18(4A):2759-62. Anticancer Res. 1998. PMID: 9703942

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

128 results

Search Page

Filters